Journal of Bone Oncology
Volume 6 • Issue 6
- ISSN: 2212-1374
- 5 Year impact factor: 3.2
- Impact factor: 3.1
Journal of Bone Oncology is an open access journal and is indexed in Clarivate Analytics' Journal Citation Reports/Science Edition as well as PubMedCentralThe Jou… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quoteJournal of Bone Oncology is an open access journal and is indexed in Clarivate Analytics' Journal Citation Reports/Science Edition as well as PubMedCentral
The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.
As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.
The areas covered by the journal include:
Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)
Preclinical models of metastasis
Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)
Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)
Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)
Bone imaging (clinical and animal, skeletal interventional radiology)
Bone biomarkers (clinical and translational applications)
Radiotherapy and radio-isotopes
Skeletal complications
Bone pain (mechanisms and management)
Orthopaedic cancer surgery
Primary bone tumours
Clinical guidelines
Multidisciplinary care
Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour
- ISSN: 2212-1374
- Volume 6
- Issue 6
- 5 Year impact factor: 3.2
- Impact factor: 3.1